Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Bispecific antibodies for cancer therapy
2009
Signal integration in the endoplasmic reticulum unfolded protein response
2007 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
2015
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
1993
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Apolipoprotein E and Amyloidogenesis
2007
Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study
2009
Restless Legs Syndrome
2008
Review: Immunoglobulin Light Chain Amyloidosis—The Archetype of Structural and Pathogenic Variability
2000
The Systemic Amyloidoses
1997 Standout
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
2002 StandoutNature
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
2009
The gut microbiota and its relationship to diet and obesity
2012
Human Genetics Shape the Gut Microbiome
2014 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Atomic structures of amyloid cross-β spines reveal varied steric zippers
2007 StandoutNature
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Mild Cognitive Impairment
2011 Standout
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 Standout
Parkinson's disease and sleep
2003
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Epidemiologie, Pathophysiologie, leitliniengerechte Diagnostik und Therapie des Schilddrüsenknotens
2010
High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly
2011
Chemical Typing of Amyloid Protein Contained in Formalin-Fixed Paraffin-Embedded Biopsy Specimens
2001
Parkinson's disease
2009 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Structure of the cross-β spine of amyloid-like fibrils
2005 StandoutNature
Serum amyloid A, the major vertebrate acute‐phase reactant
1999
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
The Biological and Chemical Basis for Tissue-Selective Amyloid Disease
2005
Proteolysis of AA Amyloid Fibril Proteins by Matrix Metalloproteinases-1, -2, and -3
2001
Zn++ inhibits both tumor necrosis factor‐mediated DNA fragmentation and cytolysis
1989
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Parkinson's disease
2015 Standout
Protein folding and misfolding
2003 StandoutNature
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for -synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT
2004
Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease
2004
Parkinson's disease: a dual‐hit hypothesis
2007
The Structure of Amyloid Fibrils by Electron Microscopy and X-Ray Diffraction
1997
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Systemic amyloidosis
2015 Standout
Thermodynamically Stable Aggregation-Resistant Antibody Domains through Directed Evolution
2008 StandoutNobel
Autonomic dysfunction in movement disorders
2001
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
1993
Introduction to current and future protein therapeutics: A protein engineering perspective
2011
Review: Amyloidogenesis—Unquestioned Answers and Unanswered Questions
2000
Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self
1988
The Amyloid State of Proteins in Human Diseases
2012 Standout
Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases
1998
Degradation and deposition of amyloid AA fibril are tissue specific
1987
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels
2012 Standout
Imaging biomarkers in Parkinson's disease
2011
Review: History of the Amyloid Fibril
2000
A Fluorescent Imaging Probe Based on a Macrocyclic Scaffold That Binds to Cellular EpCAM
2015
Domain Stability in Immunoglobulin Light Chain Deposition Disorders
1997
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Strategies and challenges for the next generation of therapeutic antibodies
2010
The Evolution of Gene Expression, Structure and Function of Transthyretin
1997
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies
2004
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Molecular Mechanisms of Amyloidosis
2003 Standout
Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin
2015
Protein aggregation: folding aggregates, inclusion bodies and amyloid
1998
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
2002
Systemic AA Amyloidosis
2012
The immunopathogenesis of sepsis
2002 StandoutNature
The Free Radical Theory of Aging
2003
Scrapie prions aggregate to form amyloid-like birefringent rods
1983 StandoutNobel
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
2015 StandoutNobel
Serum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-23
2006
Changes in Human Serum Amyloid A and C-Reactive Protein after Etiocholanolone-Induced Inflammation
1978
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
1997 Standout
Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy
1999
Amyloidosis of the AL type
1979
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Purification and structural studies of a major scrapie prion protein
1984 StandoutNobel
Alternative molecular formats and therapeutic applications for bispecific antibodies
2015
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis
2001
Coexistence of Protein AA and Immunoglobulin Light‐Chain Fragments in Amyloid Fibrils
1976
Schilddrüsenkarzinom – Klinik und Diagnostik
2010
Idiopathic REM sleep behavior disorder
2005
Imaging linear birefringence and dichroism in cerebral amyloid pathologies
2003
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Characterization of five human serum amyloid A1alleles
1994
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Programmed Cell Death Induced by Ceramide
1993 StandoutScience
Some properties of antisera to serum amyloid A protein (SAA): inhibition of precipitation by complexing of SAA to albumin.
1976
Amyloid Deposits and Amyloidosis
1980 Standout
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.
1991 StandoutNobel
Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts
2014 StandoutNobel
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients
2011
Helical Polymers: Synthesis, Structures, and Functions
2009 Standout
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
2018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.
1977
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD
2005
Evidence That Amyloidogenic Light Chains Undergo Antigen-Driven Selection
1998
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Some Speculations about Prions, Amyloid, and Alzheimer's Disease
1984 StandoutNobel
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Protein folding pathology in domestic animals
2004
Works of R. Linke being referenced
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations
2018
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
2017
The classification of amyloid deposits in clinicopathological practice
1996
Catumaxomab
2010
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states
2000
Schilddrüsenultraschallscreening (Initiative Papillon)
2003
Identification of λ light chain amyloid in eight canine and two feline extramedullary plasmacytomas
1997
Intestinal multinodular Aλ-amyloid deposition associated with extramedullary plasmacytoma in three dogs: Clinicopathological and immunohistochemical studies
1998
Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
2011
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder
2000
High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits.
1995
Cutaneous lymphatic amyloid deposits in 'Hungarian-type' familial transthyretin amyloidosis: a case report
2002
The Precursor Molecule of a Vλ II-Immunoglobulin Light Chain-Derived Amyloid Fibril Protein Circulates Precleaved
1993
Pharmacokinetics and tissue distribution of idarubicin and its active metabolite idarubicinol in the rabbit
1997
Striatal dopamine transporter binding in early to moderately advanced Parkinsonʼs disease: monitoring of disease progression over 2 years
2001
Increased Muscle Activity During Rapid Eye Movement Sleep Correlates with Decrease of Striatal Presynaptic Dopamine Transporters. IPT and IBZM SPECT Imaging in Subclinical and Clinically Manifest Idiopathic REM Sleep Behavior Disorder, Parkinson's Disease, and Controls
2003
Chemical heterogeneity of amyloid in the carpal tunnel syndrome
1987
Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)
1996
Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
1975
A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis.
1996
Fibrin-fibronectin compounds in human ovarian tumor ascites and their possible relation to the tumor stroma.
1988
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome
2001
Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis
1990
High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
1990
Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin-fixed tissue.
1983
Light Microscopic, Ultrastructural, and Immunohistochemical Examinations of Two Calcifying Epithelial Odontogenic Tumors (CEOT) in a Dog and a Cat
1994
The formation of amyloid-like fibrils in vitro from Bence Jones Proteins of the VlambdaI subclass.
1973
Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
1986
Clinical benefit of catumaxomab in malignant ascites in patient subpopulations in a pivotal phase II/III trial
2009